Citations

Clear

4847 citation(s) found for "Yu, Eric".

Sorting nexin 1 loss results in increased oxidative stress and hypertension
Yang, Jian , Asico, Laureano D. , Beitelshees, Amber L. , Feranil, Jun, Wang, Xiaoyan , Jones, John E., Armando, Inés , Cuevas, Santiago , Schwartz, Gary L. , Gums, John G. , Chapman, Arlene B. , Boerwinkle, Eric , Johnson, Julie A. , Felder, Robin A. , Weinman, Edward J., Zeng, Chunyu , José, Pedro A. , Villar, Van Anthony M., Beitelshees, Amber L. , Turner, Stephen T. , Chapman, Arlene B. , Cooper‐DeHoff, Rhonda M.

Mayo Clinic

The FASEB Journal | April 15, 2020 | Volume: 34 | Issue: 6 | Pages: 7941-7957

10.1096/fj.201902448r | PMID 32293069 Get It

Abstract Acute renal depletion of sorting nexin 1 (SNX1) in mice results in blunted natriuretic response and hypertension due to impaired dopamine D 5 receptor (D 5 R) activity. We elucidated the molecular mechanisms for these phenotypes in Snx1 −/− mice. These mice had increased renal expressions of angiotensin II type 1 receptor (AT 1 R), NADPH oxidase (NOX) subunits, D 5 R, and NaCl cotransporter. Basal reactive oxygen species (ROS), NOX activity, and blood pressure (BP) were also higher in Snx1 ‐/‐ mice, which were normalized by apocynin, a drug that prevents NOX assembly. Renal proximal tubule (RPT) cells from hypertensive (HT) Euro‐American males had deficient SNX1 activity, impaired D 5 R endocytosis, and increased ROS compared with cells from normotensive (NT) Euro‐American males. siRNA‐mediated depletion of SNX1 in RPT cells from NT subjects led to a blunting of D 5 R agonist‐induced increase in cAMP production and decrease in Na + transport, effects that were normalized by over‐expression of SNX1. Among HT African‐Americans, three of the 12 single nucleotide polymorphisms interrogated for the SNX1 gene were associated with a decrease in systolic BP in response to hydrochlorothiazide (HCTZ). The results illustrate a new paradigm for the development of hypertension and imply that the trafficking protein SNX1 may be a crucial determinant for hypertension and response to antihypertensive therapy.
LeafCutterMD: an algorithm for outlier splicing detection in rare diseases
Jenkinson, Garrett , Li, Yang , Basu, Shubham , Cousin, Margot A. , Oliver, Gavin R. , Klee, Eric W.

Mayo Clinic

Bioinformatics | April 15, 2020 | Volume: 36 | Issue: 17 | Pages: 4609-4615

10.1093/bioinformatics/btaa259 | PMID 32315392 Get It

Abstract Motivation Next-generation sequencing is rapidly improving diagnostic rates in rare Mendelian diseases, but even with whole genome or whole exome sequencing, the majority of cases remain unsolved. Increasingly, RNA sequencing is being used to solve many cases that evade diagnosis through sequencing alone. Specifically, the detection of aberrant splicing in many rare disease patients suggests that identifying RNA splicing outliers is particularly useful for determining causal Mendelian disease genes. However, there is as yet a paucity of statistical methodologies to detect splicing outliers. Results We developed LeafCutterMD, a new statistical framework that significantly improves the previously published LeafCutter in the context of detecting outlier splicing events. Through simulations and analysis of real patient data, we demonstrate that LeafCutterMD has better power than the state-of-the-art methodology while controlling false-positive rates. When applied to a cohort of disease-affected probands from the Mayo Clinic Center for Individualized Medicine, LeafCutterMD recovered all aberrantly spliced genes that had previously been identified by manual curation efforts. Availability and implementation The source code for this method is available under the opensource Apache 2.0 license in the latest release of the LeafCutter software package available online at http://davidaknowles.github.io/leafcutter. Supplementary information Supplementary data are available at Bioinformatics online.
Health Systems Science in Medical Education: Unifying the Components to Catalyze Transformation
Gonzalo, Jed D. , Chang, Anna , Starr, Stephanie R. , Holmboe, Eric S. , Wolpaw, Daniel R. , Dekhtyar, Michael

Mayo Clinic

Academic Medicine | April 14, 2020 | Volume: 95 | Issue: 9 | Pages: 1362-1372

10.1097/acm.0000000000003400 | PMID 32287080 Get It

Medical education exists in the service of patients and communities and must continually calibrate its focus to ensure the achievement of these goals. To close gaps in U.S. health outcomes, medical education is steadily evolving to better prepare providers with the knowledge and skills to lead patient- and systems-level improvements. Systems-related competencies, including high-value care, quality improvement, population health, informatics, and systems thinking, are needed to achieve this but are often curricular islands in medical education, dependent on local context, and have lacked a unifying framework. The third pillar of medical education—health systems science (HSS)—complements the basic and clinical sciences and integrates the full range of systems-related competencies. Despite the movement toward HSS, there remains uncertainty and significant inconsistency in the application of HSS concepts and nomenclature within health care and medical education. In this Article, the authors (1) explore the historical context of several key systems-related competency areas; (2) describe HSS and highlight a schema crosswalk between HSS and systems-related national competency recommendations, accreditation standards, national and local curricula, educator recommendations, and textbooks; and (3) articulate 6 rationales for the use and integration of a broad HSS framework within medical education. These rationales include: (1) ensuring core competencies are not marginalized, (2) accounting for related and integrated competencies in curricular design, (3) providing the foundation for comprehensive assessments and evaluations, (4) providing a clear learning pathway for the undergraduate–graduate–workforce continuum, (5) facilitating a shift toward a national standard, and (6) catalyzing a new professional identity as systems citizens. Continued movement toward a cohesive framework will better align the clinical and educational missions by cultivating the next generation of systems-minded health care professionals.
Albuterol Improves Alveolar‐Capillary Membrane Conductance in Healthy Humans
Snyder, Eric M., Johnson, Bruce D.

Mayo Clinic

The FASEB Journal | April 10, 2020 | Volume: 21 | Issue: 5 | Pages: No page available

10.1096/fasebj.21.5.a554-c Get It

The Beta‐2 adrenergic receptors (β 2 ARs) are located on alveolar cells and the pulmonary lymphatics and regulate lung fluid clearance through activation of epithelial sodium channels on the alveolar cells and through the relaxation of the lymphatic vessels. We sought to determine the influence of an inhaled β 2 ‐selective agonist on alveolar‐capillary conductance (DM) and pulmonary capillary blood volume (Vc) in healthy humans. To determine this, we assessed the diffusing capacity of the lungs for carbon monoxide (DLCO) and nitric oxide before and every 15 minutes for one‐hour following the administration of nebulized albuterol (2.5mg, diluted to 3ml) in 28 healthy subjects (age=28±5yrs, ht=171±14cm, wt=75±17kg, BMI=26±8kg/m 2 , values are mean±SD). Cardiac output (Q, determined via acetylene wash‐in), heart rate (HR), stroke volume (SV), systemic vascular resistance (SVR), blood pressure (BP), and oxygen saturation (SaO2) were also assessed at baseline and following the administration of albuterol. Albuterol resulted in elevations in HR, Q, and SV as well as a drop in SVR (% change from baseline, HR=4±11, 4±8, 4±8, and 4±8%; Q=15±17, 12±17, 9±19, and 4±17%; SV= 24±32, 16±27, 11±28, and 14±23%; and SVR= −15±12, −12±16, −7±20, and −4±17, at 15, 30, 45, and 60 minutes post‐albuterol, respectively, P‐ANOVA<0.05), but no change in BP. There was no change in DLCO, a decrease in Vc and an increase in DM when assessed alone or when corrected for Vc (%change from baseline, Vc=5±37, −5±30, −12±35, and −20±26%, DM= 0±18, 1±18, 6±22, and 5±19%; DM/Vc=10±44, 17±48, 47±70, and 48±70%, at 15, 30, 45, and 60 minutes post‐nebulization, respectively, p<0.05). These data suggest that the administration of albuterol improves alveolar‐capillary conductance in healthy humans, despite a small decrease in pulmonary capillary blood volume.
Immunohistochemical findings in human pituitaries following traumatic brain injury
Salehi, Fateme , Kovács, Kálmán, Pfeifer, Eric A., Scheithauer, Bernd W., Cusimano, Michael D.

Mayo Clinic

The FASEB Journal | April 10, 2020 | Volume: 21 | Issue: 5 | Pages: No page available

10.1096/fasebj.21.5.a398-b Get It

Following traumatic brain injury (TBI) approximately 25% of patients develop partial or complete hypopituitarism (HP). In our previous histologic study we found no changes in the pituitaries of patients who died instantly after TBI (Group I). In 43% of patients who survived 1‐7 days acute pituitary infarcts were apparent (Group II). In the present work, 3 group I and 7 group II pituitaries with infarcts were selected for histological and immunohistochemistry (IH) evaluation. IH was performed for adenohypophyseal hormones by the streptavidin‐biotin‐peroxidase method. In group I pituitaries, no histological changes were found and IH showed normal distribution and intensity for GH, PRL, ACTH, TSH, FSH, LH and α‐subunit (α‐SU). In group II pituitaries acute infarct (size range: 10% to 80%) was evident. IH in the non‐necrotic areas revealed no significant change. In the area of early necrosis the dying cells were still immunopositive (IP) for GH, PRL, ACTH, TSH, FSH, LS, and α‐SU. Even in the necrotic cells with loss of cell membrane, nuclear pyknosis, rhexis and lysis IP cytoplasms were still apparent indicating that hormone release is affected by ischemia. Subsequently the intensity of IP cells gradually decreased and IP granules leaked out from the necrotic cells and were seen extracellularly. In conclusion infarction and loss of adenohypophyseal cells may contribute to HP but other factors should also be considered.
Essential role of prostacyclin in regenerative function of human endothelial progenitor cells
He, Tongrong , Lam, Chen‐Fuh , Marrotte, Eric J. , Katušić, Zvonimir S. , d’Uscio, Livius V.

Mayo Clinic

The FASEB Journal | April 10, 2020 | Volume: 21 | Issue: 5 | Pages: No page available

10.1096/fasebj.21.5.a185-d Get It

The mechanisms underlying regenerative function of endothelial progenitor cells (EPCs) are not completely understood. Since previous studies from several groups including ours suggest that biosynthesis of NO in EPCs is low, the present study was designed to determine ability of EPCs to produce and release prostacyclin (PGI 2 ). Outgrowth (“late”) EPCs were obtained from peripheral blood of healthy subjects. Enzymatic activity of eNOS was significantly lower in EPCs as compared to eNOS activity in human coronary endothelial cells (CAECs) (n=4‐6 subjects, P<0.05). In contrast, production and release of PGI 2 was four fold higher in EPCs as compared to CAECs (n=3, P<0.05). This was associated with significantly higher expression of cyclooxygenase‐1 (COX‐1) protein in EPCs whereas levels of COX‐2 protein were not different between progenitor and mature endothelial cells. Production of thromboxane A 2 and prostaglandin E 2 were low and identical in EPCs and CAECs. Most importantly, inhibition of COX isoforms with indomethacin impaired pro‐angiogenic effect of EPCs as assessed by in vitro tube formation assay (n=4‐6, P<0.05). Cell proliferation was also significantly reduced after inhibition of COX isoforms with indomethacin or inactivation of PGI 2 ‐synthase by siRNA (n=4‐6, P<0.05). Our findings suggest that production and release PGI 2 is an important mechanism contributing to regenerative capability of EPCs.
Combined influence of inspiratory loading and locomotor subsystolic cuff inflation on cardiovascular responses during submaximal exercise
Smith, Joshua R. , Bruhn, Eric J., Berg, Jessica, Nur, Amran A., Villarraga, Nicolas , Olson, Thomas P. , Berg, Jessica D, Smith, Joshua R

Mayo Clinic

Journal of Applied Physiology | April 2, 2020 | Volume: 128 | Issue: 5 | Pages: 1338-1345

10.1152/japplphysiol.00781.2019 | PMID 32240016 Get It

Reflexes arising from the respiratory and locomotor muscles influence cardiovascular regulation during exercise. However, it is unclear how the respiratory and locomotor muscle reflexes interact when simultaneously stimulated. Herein, we demonstrate that stimulation of the respiratory and locomotor muscle reflexes yielded additive cardiovascular responses during submaximal exercise.
Prognostic value of interim FDG-PET in diffuse large cell lymphoma: results from the CALGB 50303 Clinical Trial
Schöder, Heiko , Polley, Mei‐Yin C. , Knopp, Michael V. , Kostakoglu, Lale , Zhang, Jun , Higley, Howard R., Kelloff, Gary J. , Liu, Heshan , Zelenetz, Andrew D. , Cheson, Bruce D. , Wagner‐Johnston, Nina D. , Friedberg, Jonathan W. , Leonard, John P. , Schwartz, Lawrence H., Wilson, Wyndham H. , Bartlett, Nancy L. , Bartlett, Nancy L , Kostakoglu, Lale , Zelenetz, Andrew D , Schöder, Heiko , Hall, Nathan C. , Kahl, Brad S. , Hsi, Eric D.

Mayo Clinic

Blood | March 31, 2020 | Volume: 135 | Issue: 25 | Pages: 2224-2234

10.1182/blood.2019003277 | PMID 32232481 Get It

Abstract As part of a randomized, prospective clinical trial in large cell lymphoma, we conducted serial fluorodeoxyglucose positron emission tomography (FDG-PET) at baseline, after 2 cycles of chemotherapy (interim PET [i-PET]), and at end of treatment (EoT) to identify biomarkers of response that are predictive of remission and survival. Scans were interpreted in a core laboratory by 2 imaging experts, using the visual Deauville 5-point scale (5-PS), and by calculating percent change in FDG uptake (change in standardized uptake value [ΔSUV]). Visual scores of 1 through 3 and ΔSUV ≥66% were prospectively defined as negative. Of 524 patients enrolled in the parent trial, 169 agreed to enroll in the PET substudy and 158 were eligible for final analysis. In this selected population, all had FDG-avid disease at baseline; by 5-PS, 55 (35%) remained positive on i-PET and 28 (18%) on EoT PET. Median ΔSUV on i-PET was 86.2%. With a median follow-up of 5 years, ΔSUV, as continuous variable, was associated with progression-free survival (PFS) (hazard ratio [HR] = 0.99; 95% confidence interval [CI], 0.97-1.00; P = .02) and overall survival (OS) (HR, 0.98; 95% CI, 0.97-0.99; P = .03). ΔSUV ≥66% was predictive of OS (HR, 0.31; 95% CI, 0.11-0.85; P = .02) but not PFS (HR, 0.47; 95% CI, 0.19-1.13; P = .09). Visual 5-PS on i-PET did not predict outcome. ΔSUV, but not visual analysis, on i-PET predicted OS in DLBCL, although the low number of events limited the statistical analysis. These data may help guide future clinical trials using PET response-adapted therapy. This trial was registered at www.clinicaltrials.gov as #NCT00118209.